Parkinson's disease/Parkinson syndromes—therapy: Dopamine agonists
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 356 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to
Cabergoline ( C b ) is a U-2 ergot derivative with a long active half-life O 4 8 h ) . In a n open rising dose study we added C b to levodopa+inhibitor in 3 0 parkinsonian patients w i t h motor fluctuations. C h m e a n daily dose w a s 13.3(6-20). given once a day. for a mean period of 1 8 . 3 16-
r i e d m a n , B r o w n U n i v e r s i t y , P r o v i d e n c e , R h o d e I s l a n d , C. C a l e y , I n s t i t u t e f o r m e n t a l H e a l t h , C r a n s t o n , R h o d e I s l a n d W e r e v i e w e d our e x p e r i e n c e w i t h f l u o x e t i n e in i d i o p a t h i c P a r
P281 AIUALYSIS OF THE MECHANISM OF ACllON UF CLOZAPINE IN t"HKKIN%JI\;"J DISEHSE 0. Gershanik'. S. tiarcfa, S. Papa and 0. Scipioni. Secci6n Entermeoaoes txtrapiramidales. Centro Neurol6gico. Hospital trances, 8uenos Aires, Argentina.
P a m p l o n a . SPAIN. Recent experimental data suggest that different s t ~i a t a l efferent pathways mediate the actions of D -l and D -2 receptor subtypes in r a t s . In order to know whether this organization is a l s o evident in primates. we studied the ability of SCH 23390